Login to Your Account

Financings Roundup

Hyperion's Series C Adds $60M for Phase III Trials of HPN-100

By Catherine Hollingsworth

Wednesday, July 1, 2009
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription